Status:
COMPLETED
Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19
Lead Sponsor:
University of Pennsylvania
Conditions:
Coronavirus
Respiratory Failure
Eligibility:
All Genders
18-100 years
Brief Summary
This is a protocol-driven observational study of lung ultrasound and focused echocardiography images obtained in the Emergency Department (ED) and Intensive Care Unit (ICU) settings as a part of exist...
Detailed Description
Background and scientific rationale: During the COVID-19 pandemic, health care systems around the world are overwhelmed. Surge of patients requiring hospital admission have led to shortages of ICU b...
Eligibility Criteria
Inclusion
- COVID-19 positive or suspected positive
- Received a cardiopulmonary ultrasound scan
Exclusion
- Did not receive a scan
- Not COVID-19 positive
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04379544
Start Date
April 23 2020
End Date
December 1 2021
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States, 19104